Quality and Manufacturing System Implications for Cell and Gene Therapy
March 23, 2022
By Matthew Kanter, Associate Consultant, MWA Consulting, and Lisa Helmonds, VP, Quality & Operations, AVS Life Sciences
With the significant advances in gene and cell therapies, companies producing breakthrough products are facing obstacles ranging from challenges with development to transitioning to commercial manufacturing. Solutions can be found in digital manufacturing execution systems (MES) and quality management systems (QMS).
Full story